|
|
(70 intermediate revisions by 7 users not shown) |
Line 1: |
Line 1: |
| == Background == | | {{Peds top}} [[pneumonia]] |
| | | ==Background== |
| | [[File:Number of deaths from pneumonia in children under 5, OWID.svg|thumb|Death rates from pneumonia in children under 5 (2017).]] |
| | [[File:Lung and diaphragm.jpg|thumb|Lobes of the lung with related anatomy.]] |
| *Most common site of infection in neonates | | *Most common site of infection in neonates |
| *Fever and tachypnea are Sn but not Sp
| |
|
| |
|
| == Causes == | | ===Bugs by Age Group=== |
| | *Newborn |
| | **[[Group B streptococci]] |
| | **[[Gram-negative bacilli]] |
| | **[[Listeria monocytogenes]] |
| | *1-3 months |
| | **[[Streptococcus pneumoniae]] |
| | **[[Chlamydia trachomatis]] |
| | **[[Haemophilus influenzae]] |
| | **[[Bordetella pertussis]] |
| | **[[Staphylococcus aureus]] |
| | *3 months-5 years |
| | **[[S. pneumoniae]] |
| | **[[S. aureus]] |
| | **[[H. influenzae]] type b |
| | **Nontypeable H. influenzae |
| | **[[C. trachomatis]] |
| | **[[Mycoplasma pneumoniae]] |
| | *5–18 years |
| | **[[M. pneumoniae]] |
| | **[[S. pneumoniae]] |
| | **[[C. pneumoniae]] |
| | **[[H. influenzae]] type b |
| | **[[S. aureus]] |
|
| |
|
| === Neonatal Pneumonia === | | ==Clinical Features== |
| | ''Fever and tachypnea are sensitive but not specific'' |
| | *[[Fever]] |
| | *[[Cough]] |
| | **Productive cough is rarely seen before late childhood |
|
| |
|
| {| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%"
| | ==Differential Diagnosis== |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | {{Pediatric fever DDX}} |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Etiology
| | {{Pediatric SOB DDX}} |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Clinical Presentation
| |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Management Approach
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="3" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" |
| |
| Bacterial
| |
|
| |
|
| [group B''Streptococcus'' (most common),''Escherichia coli'', ''Listeria monocytogenes'', ''Haemophilus influenzae ''B, ''S. pneumoniae'',''Klebsiella'' species, ''Enterobacter aerogenes''] | | ==Evaluation== |
| | [[File:PneumonisWedge09.jpg|thumb|[[CXR]] showing prominent wedge-shape area of airspace consolidation in the right lung, characteristic of bacterial [[pneumonia]].]] |
| | [[File:CT scan of the chest, demonstrating right-sided pneumonia.jpg|thumb|CT chest showing right sided pneumonia]] |
| | [[File:PNA_US.gif|thumb|Hepatization of the lung and dynamic air bronchograms present in patient with LLL pneumonia. Source: POCUS Atlas]] |
| | ===Workup=== |
| | ====Likely Outpatient==== |
| | *Imaging |
| | **[[CXR]], consider for: |
| | ***Age 0-3mo (as part of sepsis workup) |
| | ***<5yr with temperature >102.2, WBC >20K and no clear source of infection |
| | ***Ambiguous clinical findings |
| | ***Pneumonia that is prolonged or not responsive to antibiotics |
| | *Consider rapid assays: |
| | **[[Covid-19]] |
| | **[[RSV]] |
| | **[[Influenza]] |
|
| |
|
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Fulminant illness w/ onset w/in 48hr of life, w/ infection likely acquired in utero from contaminated amniotic fluid environment.
| | ====Sick/Likely Inpatient==== |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Full evaluation for sepsis (blood and urine cultures, chest radiographs, and complete blood count). The blood culture results are typically negative. Two culture samples may increase diagnostic yield fourfold.
| | ''Above plus:'' |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | *CBC |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="2" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Respiratory distress, unstable temperature (high or low), irritability or lethargy, tachycardia and poor feeding may be present.
| | *Chemistry |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | A lumbar puncture should be done if there are no contraindications.
| | *Blood/nasal culture are low yield |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | **In prospective study, 91 blood cultures needed for one positive result for CAP; but in ICU one child had bacteremia for every 24 cultures obtained, one for every 12 with parapneumonic effusion <ref> Prevalence, risk factors, and outcomes of bacteremic pneumonia in children. Pediatrics. 2019 Jun 19. </ref> |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Hospitalization, supportive care (<small>O</small><sub>2</sub>), and parenteral antibiotics (ampicillin and gentamicin, adjusts as per culture and sensitivities when available).<br/>
| | **consider for sicker ones, those with effusions |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | *IDSA does ''not'' support using initial serum [[procalcitonin]] levels to determine whether empiric antibiotics should be initiated. |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Nosocomial infections in premature infants (''Staphylococcus aureus'',''Pseudomonas aeruginosa'')
| | **Clinical judgement ''plus'' radiographic evidence alone should guide therapy (strong recommendation, moderate quality of evidence) |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Same as for common bacterial etiology.
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Same as for common bacterial etiology.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="5" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | ''Chlamydia''
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="2" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Develops in 3%–16% of exposed neonates (in colonized mothers).
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Sepsis evaluation as indicated.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | CXR may show hyperinflation with interstitial infiltrates.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="3" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Usually occurs after 3 wk of age, accompanied by conjunctivitis in one half of cases. Often afebrile, tachypneic, with prominent "staccato" cough. Wheezing uncommon.
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Definitive diagnosis by nasopharyngeal swab PCR or cultures.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Eosinophilia may be seen on peripheral blood count.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Treatment: macrolide (erythromycin, clarithromycin, or azithromycin).
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="6" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" |
| |
| ''Bordetella pertussis'' | |
| | |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="6" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | In addition to pneumonia, may causes paroxysms of cough, ± cyanosis and post-tussive emesis in otherwise well-looking infant. Characteristic whoop is not present in neonates. Apnea may be the only symptom. Suspect when adult caregiver also has persistent cough.
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Sepsis evaluation as indicated.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Diagnosis via nasopharyngeal swab for PCR and/or culture.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Lymphocytosis in peripheral blood count is nonspecific but supports the diagnosis.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Macrolides are efficient against ''B. pertussis'' but is not approved by the U.S. Food and Drug Administration for infants <6 mo.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | No available data on efficacy of azithromycin or clarithromycin in infants <1 mo old, but case series show less adverse effects with azithromycin.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Neonates need to be admitted during treatment and monitored for severe adverse effects.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="6" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" |
| |
| ''Mycobacterium tuberculosis''
| |
|
| |
|
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="2" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Half of infants born to actively infected mothers develop TB if not immunized or treated.
| | ===Diagnosis=== |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Sepsis evaluation as for bacterial pneumonia.
| | *Absence of tachypnea, respiratory distress, and rales/decreased breath sounds rules-out with 100% sensitivity |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | *[[CXR]] |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | CXR, culture of urine, gastric and tracheal aspirates.
| | **Cannot differentiate between viral and bacterial (but lobar infiltrate more often bacterial) |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | **May have negative CXR early in disease or in cases of dehydration; infiltrate may "blossom" after providing rehydration and repeat imaging<ref>Feldman C. Pneumonia in the elderly. Clin Chest Med. 1999;20(3):563-573. doi:10.1016/s0272-5231(05)70236-7</ref> |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="3" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | May be acquired via transplacental means, aspiration/ingestion of infected amniotic fluid, or postnatal airborne transmission.
| | **Absence of CXR findings does not preclude diagnosis; high clinical suspicion with adventitious breath sounds can be consistent with pneumonia despite negative imaging |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Skin testing not sensitive in neonates.
| | **Immunocompromised patients may not manifest radiographic evidence of pneumonia despite suggestive clinical findings |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | **Clinical and radiographic findings do not necessarily correspond: the patient may be improving clinically despite having a worsening appearance on the CXR |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Routine anti-TB treatment.
| | *[[Ultrasound]] |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | **Can be considered as an alternative to CXR |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="2" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Supportive treatment as needed.
| | **Sensitivity 82% and specificity 94% (adults)<ref>Staub LJ, Mazzali Biscaro RR, Kaszubowski E, Maurici R. Lung Ultrasound for the Emergency Diagnosis of Pneumonia, Acute Heart Failure, and Exacerbations of Chronic Obstructive Pulmonary Disease/Asthma in Adults: A Systematic Review and Meta-analysis. J Emerg Med. 2019;56(1):53-69. doi:10.1016/j.jemermed.2018.09.009</ref> |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Often presents with nonspecific systemic symptoms with multi-organ involvement (fever, failure to thrive, respiratory distress, organomegaly).
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="6" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Viral pneumonia (respiratory syncytial virus, adenovirus, human metapneumovirus, influenza, parainfluenza)
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="2" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Initial upper respiratory illness progressing to respiratory distress and feeding difficulty.
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Sepsis evaluation as indicated.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="2" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Viral testing (direct antigen detection/PCR/cultures) of nasopharyngeal washings (swab).
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Hypoxia and apnea may be present.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="3" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Often indistinguishable from bronchiolitis.
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Rate of concurrent bacterial infections in confirmed viral infection is low.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | CXR for significant respiratory distress.
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Supportive therapy; monitoring for apnea in young and premature infants.
| |
| |}
| |
|
| |
|
| === Infants and Children === | | ==Management== |
| | {{Pediatric pneumonia treatment}} |
|
| |
|
| *More likely to have viral cause
| | ==Disposition== |
| **Consider secondary bacterial pneumonia if URI progresses to lower tract symptoms
| | ''All Children less than 2 months should be hospitalized<ref>AAP. Management of Communty-Acquired Pneumonia in Infants and Children Older than 3 Months of Age. Pediatrics. Vol 128 No 6 December 1, 2011</ref>'' |
| ***Pneumococus, H. flu, staph, pertussis | | ===Consider Admission For=== |
| **If age >5 consider mycoplasma (treat w/ macrolide) | | *Age: <2-3 months old |
| | *History of severe or relevant congenital disorders |
| | *Immune suppression (HIV, SCD, malignancy) |
| | *Toxic appearance/respiratory distress |
| | *SpO2 <90-93% |
| | *Vomiting/dehydration |
| | *Unstable social environment |
|
| |
|
| == Diagnosis == | | ==See Also== |
| | *[[Pneumonia (Main)]] |
| | *[[Pediatric fever]] |
|
| |
|
| *Absence of tachypnea, resp distress, and rales/decr BS rules-out with 100% sp
| | ==References== |
| **Productive cough is rarely seen before late childhood
| | <references/> |
| *Imaging
| |
| **CXR is not the gold standard!
| |
| **Cannot differentiate between viral and bact (but lobar infiltrate more often bacterial)
| |
| **Consider for:
| |
| ***Age 0-3mo (part of w/u for sepsis)
| |
| ***<5yr w/ temp >102.2, WBC >20K and no clear source of infection
| |
| ***Ambiguous clinical findings
| |
| ***PNA that is prolonged or not responsive to abx
| |
| *Consider rapid assays for RSV, influenza
| |
| *Blood/nasal culture are low yield
| |
|
| |
|
| == Treatment ==
| | [[Category:Pediatrics]] |
| | [[Category:ID]] |
| | [[Category:Pulmonary]] |